Picture of CK Life Sciences Intl (Holdings) logo

775 — CK Life Sciences Intl (Holdings) News Story

0.000.00%
hk flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMid CapNeutral

Brief: Dogwood Therapeutics, Inc. Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2b Development

Jan 12 (Reuters) - CK Life Sciences Intl (Holdings) Inc 0775.HK:

DOGWOOD THERAPEUTICS, INC. ANNOUNCES FINANCING OF UP TO $26.8 MILLION TO PROGRESS HALNEURON® THROUGH PHASE 2B DEVELOPMENT

Source text: ID:nGNX3CkQW1

Further company coverage: 0775.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on CK Life Sciences Intl (Holdings)

See all news